SCHEMBL23069461

SCHEMBL23069461

[CH2][CH]CC(C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121203 0.79
SCHEMBL2121208 0.79
SCHEMBL17049219 0.78
SCHEMBL57503 0.78
SCHEMBL56450 0.74
SCHEMBL6083123 0.72
SCHEMBL276265 0.72
SCHEMBL713895 0.72
SCHEMBL22804132 0.72
SCHEMBL7753360 0.72 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324809-A1 ATP-REGULATED POTASSIUM CHANNEL OPENERS AND USES THEREOF SALZMAN GROUP LTD (IL) 2022-10-13 US disclosed
EP-4025300-A1 ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE AND USES THEREOF Salzman Group Ltd. (IL) 2022-07-13 EP disclosed
WO-2021044413-A1 ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE AND USES THEREOF SALZMAN GROUP LTD. (IL) 2021-03-11 WO disclosed